{"title":"经导管瓣内瓣植入退化莲花瓣的Evolut R","authors":"L. Conzelmann","doi":"10.19080/jocct.2019.14.555893","DOIUrl":null,"url":null,"abstract":"Degeneration of bioprosthesis also occurs in transcatheter aortic valve implantation. Treatment option in severe bioprosthetic failure is either surgical aortic valve replacement or transcatheter valve-in-valve implantation. Information about feasibility and outcome of the latter interventions is sparse. was to an A gradient of 27/18mmHg was measured at discharge. she represented with Echocardiography revealed a degenerated TAVI-bioprosthesis with an orifice area of 0.8cm² and a Pmax/mean of 90/50mmHg. to the restricted condition and comorbidities of this patient (logistic EuroSCORE I 32.75%) a valve-in-valve procedure was discussed. Meticulous planning including coronary angiography and CT-scan revealed an inner valve diameter of 18mm, a height of 20mm,","PeriodicalId":73635,"journal":{"name":"Journal of cardiology & cardiovascular therapy","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Valve-in-Valve Transcatheter Aortic Valve Implantation of an Evolut R in a Degenerated Lotus Valve\",\"authors\":\"L. Conzelmann\",\"doi\":\"10.19080/jocct.2019.14.555893\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Degeneration of bioprosthesis also occurs in transcatheter aortic valve implantation. Treatment option in severe bioprosthetic failure is either surgical aortic valve replacement or transcatheter valve-in-valve implantation. Information about feasibility and outcome of the latter interventions is sparse. was to an A gradient of 27/18mmHg was measured at discharge. she represented with Echocardiography revealed a degenerated TAVI-bioprosthesis with an orifice area of 0.8cm² and a Pmax/mean of 90/50mmHg. to the restricted condition and comorbidities of this patient (logistic EuroSCORE I 32.75%) a valve-in-valve procedure was discussed. Meticulous planning including coronary angiography and CT-scan revealed an inner valve diameter of 18mm, a height of 20mm,\",\"PeriodicalId\":73635,\"journal\":{\"name\":\"Journal of cardiology & cardiovascular therapy\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of cardiology & cardiovascular therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.19080/jocct.2019.14.555893\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiology & cardiovascular therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/jocct.2019.14.555893","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
生物瓣膜的退化也发生在经导管主动脉瓣植入术中。严重生物瓣膜衰竭的治疗选择是外科主动脉瓣置换术或经导管瓣膜植入术。关于后一种干预措施的可行性和结果的信息很少。在放电时测量到27/18mmHg的A梯度。超声心动图显示TAVI生物瓣膜退化，瓣口面积为0.8cm²，Pmax/平均值为90/50mmHg。针对该患者的限制性条件和合并症（logistic EuroSCORE I 32.75%），讨论了瓣膜置换术。冠状动脉造影和CT扫描等精细规划显示瓣膜内径为18mm、高度为20mm，
Valve-in-Valve Transcatheter Aortic Valve Implantation of an Evolut R in a Degenerated Lotus Valve
Degeneration of bioprosthesis also occurs in transcatheter aortic valve implantation. Treatment option in severe bioprosthetic failure is either surgical aortic valve replacement or transcatheter valve-in-valve implantation. Information about feasibility and outcome of the latter interventions is sparse. was to an A gradient of 27/18mmHg was measured at discharge. she represented with Echocardiography revealed a degenerated TAVI-bioprosthesis with an orifice area of 0.8cm² and a Pmax/mean of 90/50mmHg. to the restricted condition and comorbidities of this patient (logistic EuroSCORE I 32.75%) a valve-in-valve procedure was discussed. Meticulous planning including coronary angiography and CT-scan revealed an inner valve diameter of 18mm, a height of 20mm,
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
